Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Opioid-Induced Constipation × methylnaltrexone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Opioid-Induced Constipation 1

Interventions

naldemedine 1 methylnaltrexone 1 Polyethylene Glycols 1 Oxycodone 1 Magnesium Hydroxide 1 Electrolytes 1 Dosage Forms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00858754 2019-11-29

Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects

Bausch Health Americas, Inc.

Phase 4 Withdrawn

Opioid-Induced Constipation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡